E-Z-Em of Westbury, NY, announced this month that it has signedan agreement with Bowman Gray School of Medicine in Winston-Salem,NC, to develop an oral contrast agent for virtual colonoscopyprocedures under investigation at the hospital. The agent
E-Z-Em of Westbury, NY, announced this month that it has signedan agreement with Bowman Gray School of Medicine in Winston-Salem,NC, to develop an oral contrast agent for virtual colonoscopyprocedures under investigation at the hospital. The agent willminimize artifacts in 3-D images of the colon that can obscureor mimic polyps in virtual colonoscopy simulations. Virtual colonoscopyis being developed as an alternative to video-based colonoscopyscreening (SCAN 7/19/95).
In other news, E-Z-Em has introduced a new remote-controlledCT contrast injection system, PercuPump II. E-Z-Em used feedbackfrom radiologists and technologists in designing the system, whichuses a touch-screen remote control and features an optional thermalprinter to print a record of each patient's procedure.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.